Phatchanat Klaihmon
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
NECTIN2 depletion impairs migration and invasion in MDA-MB-231 breast cancer cells through LIMK1-associated cytoskeletal remodeling.
Journal: PloS one
Published: April 22, 2026
A human iPSC model with LATS1/2 knockdown (MUSIi012-A-9) for investigating Hippo signaling in stem cell.
Journal: Stem cell research
Published: April 12, 2026
Temporal Lysophosphatidic Acid Supplementation Enhances Megakaryocyte Differentiation and Platelet Production From Human Hematopoietic Progenitors.
Journal: Cell biology international
Published: December 22, 2025
The novel combination of small-molecule inhibitors increases the survival and colony formation capacity of human induced pluripotent stem cells after single-cell dissociation.
Journal: Science progress
Published: May 13, 2025
Platelet Responses to Urethane Dimethacrylate-Based Bone Cements Containing Monocalcium Phosphate/ε-Polylysine: Role of ε-Polylysine in In Vitro Wound Healing Induced by Platelet-Derived Growth Factor-BB.
Journal: ACS materials Au
Published: October 18, 2024
Point-of-care manufacturing of anti-CD19 CAR-T cells using a closed production platform: Experiences of an academic in Thailand.
Journal: Molecular therapy. Oncology
Published: May 20, 2024
Generation of a human iPSC cell line (MUSIi017-A) from a donor with O negative blood type.
Journal: Stem cell research
Published: March 02, 2024
Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion.
Journal: Experimental hematology & oncology
Published: January 15, 2024
OGT and OGA gene-edited human induced pluripotent stem cells for dissecting the functional roles of O-GlcNAcylation in hematopoiesis.
Journal: Frontiers in cell and developmental biology
Published: December 27, 2023
Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib.
Journal: Scientific reports
Published: December 08, 2023
Last Updated: 09/26/2026